NO20092024L - En farmasoytisk sammensetning med antipsykotisk, antidepressiv eller antiepileptisk aktivitet med redusert bivirkning - Google Patents
En farmasoytisk sammensetning med antipsykotisk, antidepressiv eller antiepileptisk aktivitet med redusert bivirkningInfo
- Publication number
- NO20092024L NO20092024L NO20092024A NO20092024A NO20092024L NO 20092024 L NO20092024 L NO 20092024L NO 20092024 A NO20092024 A NO 20092024A NO 20092024 A NO20092024 A NO 20092024A NO 20092024 L NO20092024 L NO 20092024L
- Authority
- NO
- Norway
- Prior art keywords
- antidepressant
- antipsychotic
- pharmaceutical composition
- side effect
- reduced side
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85617706P | 2006-11-02 | 2006-11-02 | |
US11/687,954 US20080108602A1 (en) | 2006-11-02 | 2007-03-19 | Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication |
PCT/HU2007/000067 WO2008053257A1 (en) | 2006-11-02 | 2007-07-23 | A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092024L true NO20092024L (no) | 2009-06-02 |
Family
ID=38595981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092024A NO20092024L (no) | 2006-11-02 | 2009-05-25 | En farmasoytisk sammensetning med antipsykotisk, antidepressiv eller antiepileptisk aktivitet med redusert bivirkning |
Country Status (20)
Country | Link |
---|---|
US (3) | US20080108602A1 (hr) |
EP (1) | EP2089032B1 (hr) |
JP (1) | JP2010509200A (hr) |
KR (1) | KR20090077973A (hr) |
AT (1) | ATE491452T1 (hr) |
AU (1) | AU2007315932A1 (hr) |
BR (1) | BRPI0717868A2 (hr) |
CA (1) | CA2668384A1 (hr) |
DE (1) | DE602007011316D1 (hr) |
DK (1) | DK2089032T3 (hr) |
HK (1) | HK1131736A1 (hr) |
HR (1) | HRP20110139T1 (hr) |
IL (1) | IL198294A (hr) |
MX (1) | MX2009004579A (hr) |
NO (1) | NO20092024L (hr) |
PL (1) | PL2089032T3 (hr) |
PT (1) | PT2089032E (hr) |
RU (1) | RU2440116C2 (hr) |
SI (1) | SI2089032T1 (hr) |
WO (1) | WO2008053257A1 (hr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009074835A1 (en) * | 2007-12-10 | 2009-06-18 | N-Gene Research Laboratories Inc. | Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity |
HUP1100444A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
HUP1100445A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
US20210220298A1 (en) * | 2018-06-29 | 2021-07-22 | Tufts Medical Center, Inc. | Methods and compositions for preventing and treating metabolic syndrome induced by antipsychotic treatment and related diseases and conditions |
HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187220A (en) * | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
HU9502843D0 (en) * | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
US6884424B2 (en) * | 1995-12-22 | 2005-04-26 | N-Gene Research Laboratories Inc. | Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
US6458371B1 (en) * | 1995-12-22 | 2002-10-01 | Medgene, Limited | Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin |
HU9701081D0 (en) * | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
HUP9701080A3 (en) * | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
EP1408966B1 (en) * | 2001-07-17 | 2008-02-20 | N-Gene Research Laboratories Inc. | Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
US6831077B2 (en) * | 2002-07-25 | 2004-12-14 | Comprehensive Neuroscience, Inc. | Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation |
HUP0401177A2 (en) * | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition for increasing the mitochondrial genesis |
-
2007
- 2007-03-19 US US11/687,954 patent/US20080108602A1/en not_active Abandoned
- 2007-07-23 AU AU2007315932A patent/AU2007315932A1/en not_active Abandoned
- 2007-07-23 PT PT07766499T patent/PT2089032E/pt unknown
- 2007-07-23 DE DE602007011316T patent/DE602007011316D1/de active Active
- 2007-07-23 RU RU2009120115/15A patent/RU2440116C2/ru not_active IP Right Cessation
- 2007-07-23 AT AT07766499T patent/ATE491452T1/de active
- 2007-07-23 JP JP2009535138A patent/JP2010509200A/ja active Pending
- 2007-07-23 CA CA002668384A patent/CA2668384A1/en not_active Abandoned
- 2007-07-23 WO PCT/HU2007/000067 patent/WO2008053257A1/en active Application Filing
- 2007-07-23 KR KR1020097011078A patent/KR20090077973A/ko not_active Application Discontinuation
- 2007-07-23 DK DK07766499.3T patent/DK2089032T3/da active
- 2007-07-23 PL PL07766499T patent/PL2089032T3/pl unknown
- 2007-07-23 SI SI200730539T patent/SI2089032T1/sl unknown
- 2007-07-23 MX MX2009004579A patent/MX2009004579A/es active IP Right Grant
- 2007-07-23 EP EP07766499A patent/EP2089032B1/en active Active
- 2007-07-23 BR BRPI0717868-9A2A patent/BRPI0717868A2/pt not_active IP Right Cessation
-
2009
- 2009-04-22 IL IL198294A patent/IL198294A/en not_active IP Right Cessation
- 2009-05-25 NO NO20092024A patent/NO20092024L/no not_active Application Discontinuation
- 2009-09-25 HK HK09108840.6A patent/HK1131736A1/xx not_active IP Right Cessation
-
2010
- 2010-08-17 US US12/858,299 patent/US20100311719A1/en not_active Abandoned
-
2011
- 2011-02-24 HR HR20110139T patent/HRP20110139T1/hr unknown
-
2015
- 2015-06-23 US US14/748,150 patent/US20150366852A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL198294A (en) | 2011-09-27 |
EP2089032A1 (en) | 2009-08-19 |
US20100311719A1 (en) | 2010-12-09 |
PT2089032E (pt) | 2011-03-23 |
HK1131736A1 (en) | 2010-02-05 |
JP2010509200A (ja) | 2010-03-25 |
US20150366852A1 (en) | 2015-12-24 |
PL2089032T3 (pl) | 2011-05-31 |
EP2089032B1 (en) | 2010-12-15 |
KR20090077973A (ko) | 2009-07-16 |
AU2007315932A1 (en) | 2008-05-08 |
US20080108602A1 (en) | 2008-05-08 |
DE602007011316D1 (de) | 2011-01-27 |
WO2008053257A1 (en) | 2008-05-08 |
CA2668384A1 (en) | 2008-05-08 |
ATE491452T1 (de) | 2011-01-15 |
BRPI0717868A2 (pt) | 2013-10-29 |
DK2089032T3 (da) | 2011-03-14 |
IL198294A0 (en) | 2010-02-17 |
SI2089032T1 (sl) | 2011-04-29 |
HRP20110139T1 (hr) | 2011-04-30 |
MX2009004579A (es) | 2009-06-05 |
RU2009120115A (ru) | 2010-12-10 |
RU2440116C2 (ru) | 2012-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL190951A0 (en) | Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose | |
TNSN08178A1 (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
WO2010084115A3 (en) | Antiviral agents | |
EP3251674A3 (en) | Antiviral azasugar-containing nucleosides | |
IL179612A (en) | Benzimidazolone carboxylic acid derivatives, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments for the treatment of conditions mediated by 5-ht4 receptor activity | |
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
WO2010088000A3 (en) | Antifibrotic compounds and uses thereof | |
EA201270800A1 (ru) | С-28 амиды модифицированных производных с-3 бетулиновой кислоты в качестве ингибиторов созревания вич | |
HK1118011A1 (zh) | 透明質酸的抗腫瘤生物結合物或以化學接合方法間接地取得的衍生物,以及其製藥用途 | |
BR112012003283A8 (pt) | sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente. | |
BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
IL188438A (en) | A heterocyclic active drug with five benzoposes, or a pharmaceutically acceptable salt and aster salts product, as well as compounds containing them and their use as @catol - o @ - @ of @ enzyme @ dead G iltransferase @@ comtI | |
NO20092024L (no) | En farmasoytisk sammensetning med antipsykotisk, antidepressiv eller antiepileptisk aktivitet med redusert bivirkning | |
DE602007010819D1 (de) | Verringerung von übergewicht oder fettsucht | |
MX2009010483A (es) | 5-oxoisoxazoles como inhibidores de lipasas y fosfolipasas. | |
WO2012085249A3 (en) | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid | |
WO2010080414A3 (en) | Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents | |
MX2009004295A (es) | Uso de un acido indazolmetoxialcanoico para reducir niveles de triglicerido, colesterol y glucosa. | |
TW200800977A (en) | A new salt | |
WO2006133194A3 (en) | Methods for treating viral infection with oral or injectible drug solution | |
WO2011058336A3 (en) | Tablet comprising gum arabic | |
WO2008041116A3 (en) | Formulations of active principles incorporated in slns suitable for transdermal administration | |
MX2012007393A (es) | Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |